This report analyses the financial performance of Shop Apotheke Europe for the 2019. You will find all the necessary details regarding company's profitability, volume growth, indebtedness and a comparison with selected peers.
Shop Apotheke Europe announced a net loss of EUR 36.3 mil in 2019, down 7.92% when compared to the last year. Sales increased 29.9% yoy to EUR 701 mil, EBITDA fell 19.4% to EUR -18.6 mil and net margin amounted to -5.17%. Shop Apotheke Europe stock appreciated 15.7% in 2019 to EUR 43.5 per share and the stock traded at 12-month trailing PE of -15.6 and EV/EBITDA of -32.2x at the end of 2019.
The key highlights are:
Sales increased 29.9% yoy to EUR 701 mil in 2019. That’s compared to average growth of 58.1% in the last three years and 0% when compared to the average annual increase in the last decade.
EBITDA amounted to EUR -18.6 mil and fell -19.4% when compared to last year. EBITDA margin reached -2.65%, up 1.09 pp when compared to 5-year average.
Company’s indebtedness rose when measured by Net Debt/Equity and reached 15.5% at the end of the year. When compared to EBITDA, net debt fell to -1.94x.
Shop Apotheke Europe netted EUR -36.3 mil to its shareholders in the last year, up 50.8% when compared to the average seen in the last five years. The company produced a return on capital of -13.9% and return on equity of -16.2% in the last year.
Shop Apotheke Europe stock traded at EUR 43.5 per share at the end of 2019 implying a market capitalization of USD 638 mil and enterprise value of USD 678 mil. This puts the stock at the 12-month trailing price to earnings of -15.6x and EV/EBITDA of -32.2x as of the end of 2019. Over the last five years, the stock price has increased by 0% a year on average and the firm generated its shareholders an average return on equity of -35.2%.
Helgi Library 
